Hormone-refractory prostate cancer: An evolving standard of care

被引：0
|
作者：
Small, EJ
Reese, DM
Vogelzang, NJ
机构：
[1] Univ Calif San Francisco, UCSF Comprehens Canc Ctr, San Francisco, CA 94115 USA
[2] Univ Chicago, Ctr Canc Res, Chicago, IL 60637 USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：61 / 67
页数：7
相关论文
共 50 条
  • [1] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [2] Hormone-refractory prostate cancer: a primer for the primary care physician
    Potvin, Kylea
    Winquist, Eric
    CANADIAN JOURNAL OF UROLOGY, 2008, 15 : 14 - 20
  • [3] Chemotherapy of the hormone-refractory prostate cancer
    Heine, K
    Wolff, JM
    AKTUELLE UROLOGIE, 2004, 35 (03) : 209 - 214
  • [4] Management of hormone-refractory prostate cancer
    Dogliotti, L
    Mosca, A
    TUMORI, 2003, : S147 - S149
  • [5] Taxanes in hormone-refractory prostate cancer
    Kang, MH
    Figg, WD
    Dahut, W
    CANCER PRACTICE, 1999, 7 (05) : 270 - 272
  • [6] Therapy of hormone-refractory prostate cancer
    Heidenreich, A
    UROLOGE, 2005, 44 (12): : 1481 - 1494
  • [7] Chemotherapy for hormone-refractory prostate cancer
    Shelley, Mike
    Harrison, Craig
    Coles, Bernadette
    Staffurth, John
    Wilt, Timothy J.
    Mason, Malcolm D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [8] Satraplatin for hormone-refractory prostate cancer
    Kerr, Cathel
    LANCET ONCOLOGY, 2007, 8 (04): : 290 - 290
  • [9] Chemotherapy in hormone-refractory prostate cancer
    de Wit, Ronald
    BJU INTERNATIONAL, 2008, 101 : 11 - 15
  • [10] Therapy of hormone-refractory prostate cancer
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4796 - 4796
12345